tiprankstipranks
Unicycive Therapeutics (UNCY)
NASDAQ:UNCY
US Market
UNCY
Unicycive Therapeutics
RESEARCH TOOLSreports
Want to see UNCY full AI Analyst Report?

Unicycive Therapeutics (UNCY) Income Statement

857 Followers

Unicycive Therapeutics Income Statement

Last quarter (Q4 2025), Unicycive Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Unicycive Therapeutics's net income was $-14.67M. See Unicycive Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Mar 23Mar 22
Total Revenue
$ 0.00$ 0.00$ 675.00K$ 951.00K$ 0.00
Gross Profit
$ -572.00K$ 0.00$ 675.00K$ 951.00K$ 0.00
Operating Expenses
$ 28.95M$ 32.12M$ 21.45M$ 19.00M$ 8.98M
Depreciation and Amortization
$ 572.00K$ 428.00K$ 284.00K$ 161.00K$ 13.00K
EBITDA
$ -25.91M$ -36.23M$ -30.18M$ -17.89M$ -9.38M
Operating Income
$ -29.52M$ -32.12M$ -20.77M$ -18.05M$ -8.98M
Other Income/Expenses
$ 2.96M$ -4.61M$ -9.77M$ -6.00K$ -1.04M
Pretax Income
$ -26.55M$ -36.73M$ -30.54M$ -18.06M$ -10.02M
Net Income
$ -26.55M$ -36.73M$ -30.54M$ -18.06M$ -10.02M
Per Share Metrics
Basic EPS
$ -1.67$ -5.60$ -1.28$ -1.20$ -8.60
Diluted EPS
$ -1.67$ -5.60$ -1.28$ -1.20$ -8.60
Weighted Average Shares Outstanding
 158.87M- 2.45M 1.51M 1.17M
Weighted Average Shares Outstanding (Diluted)
 158.87M- 2.45M 1.51M 1.17M
Currency in USD

Unicycive Therapeutics Earnings and Revenue History